CAP inhibition facilitates the identification of the primary sensitizing venom in patients with clinically presumed Vespa crabro stings: implications for venom immunotherapy selection.

Furlani M, Visentini D, Busa M, Scarpa A, Borghesan F, Rizzo F, Pravettoni V, Fabris M, Villalta D

Open source

DOI
10.23822/eurannaci.1764-1489.463
Published
2026 Nov 10
Container
European annals of allergy and clinical immunology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.23822/eurannaci.1764-1489.463,
  title = {CAP inhibition facilitates the identification of the primary sensitizing venom in patients with clinically presumed Vespa crabro stings: implications for venom immunotherapy selection.},
  author = {Furlani M and Visentini D and Busa M and Scarpa A and Borghesan F and Rizzo F and Pravettoni V and Fabris M and Villalta D},
  year = {2026},
  journal = {European annals of allergy and clinical immunology},
  doi = {10.23822/eurannaci.1764-1489.463},
  url = {https://doi.org/10.23822/eurannaci.1764-1489.463}
}

RIS

TY  - JOUR
TI  - CAP inhibition facilitates the identification of the primary sensitizing venom in patients with clinically presumed Vespa crabro stings: implications for venom immunotherapy selection.
AU  - Furlani M
AU  - Visentini D
AU  - Busa M
AU  - Scarpa A
AU  - Borghesan F
AU  - Rizzo F
AU  - Pravettoni V
AU  - Fabris M
AU  - Villalta D
PY  - 2026
JO  - European annals of allergy and clinical immunology
DO  - 10.23822/eurannaci.1764-1489.463
UR  - https://doi.org/10.23822/eurannaci.1764-1489.463
ER  - 

APA

M, F., D, V., M, B., A, S., F, B., F, R., V, P., M, F., & D, V. (2026). CAP inhibition facilitates the identification of the primary sensitizing venom in patients with clinically presumed Vespa crabro stings: implications for venom immunotherapy selection.. European annals of allergy and clinical immunology. https://doi.org/10.23822/eurannaci.1764-1489.463

Source records